Current Atherosclerosis Reports

Article	Citations
Revascularization Options for Left Main Disease: What Clinicians Need to Know	91
Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth?	90
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?	85
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management	73
The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes	67
A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment	60
The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis	60
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions	58
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?	57
Heart Transplant, Kawasaki Disease, and Bone Marrow Transplant: Are There Consequences?	57
The Effects of FABP4 on Cardiovascular Disease in the Aging Population	56
Watermelon and l-Citrulline in Cardio-Metabolic Health: Review of the Evidence 2000–2020	50
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management	50
DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm	48
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice	47
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators	46
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond	45
Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women	43
Spontaneous Coronary Artery Dissection (SCAD): Unveiling the Enigma of the Unexpected Coronary Event	43
Salutary Effects of Nutritional Ketosis for the Diseased Human Heart	40
The Emerging Specialty of Cardio-Rheumatology	38
Programmable Genome-Editing Technologies as Single-Course Therapeutics for Atherosclerotic Cardiovascular Disease	38
Inflammation in the Peri-ACS Period: Ready for Prime Time?	36
Correction to: Beta‑blockers for Atherosclerosis Prevention: a Missed Opportunity?	36
Myeloid Cells in Abdominal Aortic Aneurysm	36

Nutrition Interventions for Youth with Dyslipidemia: Who, What, When, and Where?	35
The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review	34
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention	34
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women	32
Recent Advances and Perspectives of Metabolomics-Based Investigations in Coronary Heart Disease	32
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?	32
GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?	32
The Role of Sleep in Cardiovascular Disease	31
Percutaneous Coronary Interventions in Women	30
Lipoprotein(a): from Causality to Treatment	30
RNA Silencing in the Management of Dyslipidemias	29
Role of RNA-binding Proteins in Regulating Cell Adhesion and Progression of the Atherosclerotic Plaque and Plaque Erosion	29
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease	27
Low LDL-C: Is It all Good News?	27
Update on Plant-Based Diets and Cardiometabolic Risk	27
Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know	26
The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger	26
Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease	25
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment	24
Stress, Vascular Smooth Muscle Cell Phenotype and Atherosclerosis: Novel Insight into Smooth Muscle Cell Phenotypic Transition in Atherosclerosis	23
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?	23
Childhood Hypertriglyceridemia: Is It Time for a New Approach?	22
Transgender Cardiovascular Health: Practical Management for the Clinician	22
Importance of Nutrition Security to CVD Prevention Efforts in the USA	22
Effects of Omega-3 Fatty Acids on Flow-mediated Dilatation and Carotid Intima Media Thickness: A Meta-analysis	21
Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?	21
Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?	20
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?	20
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?	20
Correction to: High-Density Lipoproteins and Serum Amyloid A (SAA)	20
Evidence Gaps in Assessments of the Healthiness of Online Supermarkets Highlight the Need for New Monitoring Tools: a Systematic Review	19
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference	19
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity	19
Noninvasive Atherosclerotic Phenotyping: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease	19
Membrane Cholesterol Interactions with Proteins in Hypercholesterolemia-Induced Endothelial Dysfunction	18
SR-B1’s Next Top Model: Structural Perspectives on the Functions of the HDL Receptor	18
Dairy Foods: Is Its Cardiovascular Risk Profile Changing?	18
Transforming Population Health Screening for Atherosclerotic Cardiovascular Disease with AI-Enhanced ECG Analytics: Opportunities and Challenges	17
Is There a Role for Imaging Youth at Risk of Atherosclerosis?	17
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know	17
Wall Shear Stress Alteration: a Local Risk Factor of Atherosclerosis	16
Clinical Management of Dyslipidemia in Infants and Toddlers	16
Brief Review: Racial and Ethnic Disparities in Cardiovascular Care with a Focus on Congenital Heart Disease and Precision Medicine	16
Gene Regulatory Networks in Coronary Artery Disease	16
Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population	16
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American College of Cardiology Conference	15
Cardiovascular Health and Disease in the Pakistani American Population	15
Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician	15
High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review	15
Targeting the Gut Microbiome to Treat Cardiometabolic Disease	15

Natural Sirtuin1 Activators and Atherosclerosis: an Overview	15
Bempedoic Acid: for Whom and When	14
What Causes Premature Coronary Artery Disease?	14
Utility of FFRCT in Patients with Chest Pain	14
Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field	14
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins	14
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults	14
Biology, Bias, or Both? The Contribution of Sex and Gender to the Disparity in Cardiovascular Outcomes Between Women and Men	14
A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms	14
Circular RNA role in Atherosclerosis Development and Progression	13
The Role of Lysyl Oxidase in the Pathological Stage of Atherosclerosis: Structural Stabilizer or Disease Driver?	13
Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading?	13
Managing Dyslipidemia in Chronic Kidney Disease: Implications for Cardiovascular and Renal Risk	13
Fixed Combination for the Treatment of Dyslipidaemia	12
Combined Dyslipidemia in Children and Adolescents: a Proposed New Management Approach	12
Anti-Inflammatory Lipid Mediators from Polyunsaturated Fatty Acids: Insights into their Role in Atherosclerosis Microenvironments	12
LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated?	11
Pregnancy Complications and Long-Term Atherosclerotic Cardiovascular Disease Risk	11
Diet, Food Insecurity, and CVD Risk in Sexual and Gender Minority Adults	11
Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics	11
Imaging Approaches to the Diagnosis of Vascular Diseases	11
Non-obstructive Plaque and Treatment of INOCA: More to Be Learned	11
Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis	11
Lipids: a Potential Molecular Pathway Towards Diastolic Dysfunction in Youth-Onset Type 2 Diabetes	11
Recent Updates in Hypertriglyceridemia Management for Cardiovascular Disease Prevention	11
Statins and Inflammation	11
Obicetrapib—the Rebirth of CETP Inhibitors?	11
Apheresis: What Should a Clinician Know?	11
Unraveling the miRNA Puzzle in Atherosclerosis: Revolutionizing Diagnosis, Prognosis, and Therapeutic Approaches	11
The TICE Pathway: Mechanisms and Potential Clinical Applications	11
Glycated Hemoglobin as an Integrator of Cardiovascular Risk in Individuals Without Diabetes: Lessons from Recent Epidemiologic Studies	11
European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges	10
Cardiovascular Disease Burden among African Migrants	10
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia	10
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions	10
HDL as a Treatment Target: Should We Abandon This Idea?	10
S-Nitrosylation: Mechanistic Links between Nitric Oxide Signaling and Atherosclerosis	9
Psychological Health and Ischemic Heart Disease in Women: A Review of Current Evidence and Clinical Considerations across the Healthspan	9
How to Handle Elevated Triglycerides: Life after PROMINENT	9
Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors	9
Gene Editing for the Treatment of Hypercholesterolemia	9
Recent Advances in Coronary Computed Tomography Angiogram: The Ultimate Tool for Coronary Artery Disease	9
Targeting Inflammatory Pathways in Atherosclerosis: Exploring New Opportunities for Treatment	9
Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme?	9
The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia	9
An Update on Nutrition Guidance for Cardiovascular Health	9
Artificial Intelligence-Enabled Point-of-Care Echocardiography: Bringing Precision Imaging to the Bedside	9
Advances, Challenges, and Progress in Cardiac Rehabilitation in Chronic CVD Management	9
Coronary and Extra-coronary Subclinical Atherosclerosis to Guide Lipid-Lowering Therapy	9
Statin Use and Hyperglycemia: Do Statins Cause Diabetes?	9
CETP Inhibitors: Should We Continue to Pursue This Pathway?	9
The Atherosclerotic Plaque Microenvironment as a Therapeutic Target	9
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?	9
Cholesterol Lowering in Older Adults: Should We Wait for Further Evidence?	9
Can Digital Health Solutions Fill in the Gap for Effective Guideline Implementation in Cardiovascular Disease Prevention: Hope or Hype?	9
Family Meals and Cardiometabolic Risk Factors in Young Children	8
LDL Transcytosis by the Arterial Endothelium—Atherosclerosis by a Thousand Cuts?	8
Achieving More Optimal Lipid Control with Non-Statin Lipid Lowering Therapy	8
Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?	8
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes	8
JAM-A: Adhesion Receptor and Signaling Regulator in Atherosclerosis	8
Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?	8
Do Statins Affect Cognitive Health? A Narrative Review and Critical Analysis of the Evidence	8
Myocardial Bridge and Atherosclerosis, an Intimal Relationship	8
Mechanisms Behind NAFLD: a System Genetics Perspective	8
Update on Sitosterolemia and Atherosclerosis	8
Correction to: Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?	7
Correction to: Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?	7
Sport as Medicine for Dyslipidemia (and Other Risk Factors)	7
The Management of Hypercholesterolemia in Patients with Neuromuscular Disorder	7
The Role of Non-statin Lipid-Lowering Medications in Youth with Hypercholesterolemia	7
Eggs and Cardiovascular Disease Risk: An Update of Recent Evidence	7
“Anti-inflammatory Therapies in Atherosclerosis – Where are we going?”	7
Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes	7
Transitioning Adolescents and Young Adults with Lipid Disorders to Adult Health Care	7
Familial Combined Hyperlipidemia: Myth or Reality?	7
The Role of Coronary Artery Calcium Testing for Value-Based Clinical Trials in Primary Prevention	7
Inclisiran: How Widely and When Should We Use It?	7
More than Just a Monolayer: the Multifaceted Role of Endothelial Cells in the Pathophysiology of Atherosclerosis	7
Correction to: Built Environment and Cardiovascular Diseases – Insights from a Global Review	7

Biomarkers Differentiating Plaque Erosion from Stable Plaque	7
Health Literacy is Essential to ASCVD Prevention in Youth	7
ADAMTS7: a Novel Therapeutic Target in Atherosclerosis	7
Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a)	7
Incidental Finding of Coronary and Non-Coronary Artery Calcium: What Do Clinicians Need To Know?	6
Alcohol Consumption and Cardiovascular Disease Risk: Placing New Data in Context	6
Double-Trouble: Atherosclerotic Risk Factors and Congenital Heart Disease	6
Rap1 in the Context of PCSK9, Atherosclerosis, and Diabetes	6
Effects of the COVID-19 Pandemic on Pediatric and Adolescent ASCVD Risk Factors	6
Mechanosensing and Mechanosignal Transduction in Atherosclerosis	6
Impact of Sex Differences on Lipids and Statin Utilization	6
The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations	6
Lipid Phenotypes and DNA Methylation: a Review of the Literature	6
Built Environment and Cardiovascular Diseases – Insights from a Global Review	6
Updates in Small Interfering RNA for the Treatment of Dyslipidemias	6
Invasive Coronary Assessment in Myocardial Ischemia with No Obstructive Coronary Arteries	6
The Pandemic of Coronary Heart Disease in the Middle East and North Africa: What Clinicians Need to Know	5
Protective Effects of Different Classes, Intensity, Cumulative Dose-Dependent of Statins Against Primary Ischemic Stroke in Patients with Type 2 Diabetes Mellitus	5
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future	5
Impact of Selective Peroxisome Proliferator-Activated Receptor (PPAR)-α Modulators and Fibrates on Microvascular Disease: Is There Still Room?	5
SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently?	5
Saturated Fat and Cardiovascular Health: Phenotype and Dietary Factors Influencing Interindividual Responsiveness	5
PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?	5
Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies	5
Sex-based Differences in Complications Following Percutaneous Coronary Interventions	5
Insight into the Mechanistic role of Colchicine in Atherosclerosis	5
Novel Therapeutics for Familial Chylomicronemia Syndrome	5
Statin Use and Coronary Artery Calcification: a Systematic Review and Meta-analysis of Observational Studies and Randomized Controlled Trials	5
Updates in Drug Treatment of Severe Hypertriglyceridemia	5
The Role of Genetics in Advancing Cardiometabolic Drug Development	5
Medical Nutrition Therapy Provided by Dietitians is Effective and Saves Healthcare Costs in the Management of Adults with Dyslipidemia	5
Telomere Length: Implications for Atherogenesis	5
Statin Intolerance: an Overview of US and International Guidance	5
Lp(a): A Rapidly Evolving Therapeutic Landscape	5
Medication Induced Dyslipidemia in Children	5